Levocarnitine

Also known as carnitine

Note: This product is not licenced in Australia at the time of publication. The information in this monograph applies to the specified brand, formulation and strength only.

Trade name

Carnitene

Presentation and preparation

200 mg/mL (volume: 5 mL)

IV administration

Give undiluted over at least 2 minutes or dilute to 0.5 to 8 mg/mL and infuse over 30 minutes or give by continuous infusion.

Maximum infusion rate: 3 mL/minute.

Haemodialysis: Give at the end of haemodialysis.

Other routes of administration

IM: Not recommended.

SC: Not recommended.

Compatible IV fluids

Levocarnitine 8 mg/mL or weaker:

Glucose 5%

Glucose 10%

Hartmann’s

Sodium chloride 0.9%

Additional information

Has been co-infused via Y-site with arginine, sodium benzoate and sodium phenylbutyrate.

Therapeutic drug monitoring maybe required; refer to local guidelines.

Discard any unused vial or ampoule contents.

Protect from light during storage.